Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pamidronate disodium 90mg inf vials
0606020P0AAADAD
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 90mg inj vials
0606020P0AAAPAP
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 90mg/10ml solution for infusion vials
0606020P0AAAHAH
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Pamidronate disodium 90mg/30ml solution for infusion vials
0606020P0AAALAL
|
Pamidronate disodium | Pamidronate disodium | Endocrine System | No data available |
|
Parathyroid hormone 1.61mg inj cartridges
0606010V0AAAAAA
|
Parathyroid hormone | Parathyroid hormone | Endocrine System | No data available |
|
Parlodel 10mg capsules
0607010B0BBADAB
|
Parlodel | Bromocriptine | Endocrine System | No data available |
|
Parlodel 1mg tablets
0607010B0BBAAAC
|
Parlodel | Bromocriptine | Endocrine System | No data available |
|
Parlodel 2.5mg tablets
0607010B0BBABAD
|
Parlodel | Bromocriptine | Endocrine System | No data available |
|
Parlodel 5mg capsules
0607010B0BBACAA
|
Parlodel | Bromocriptine | Endocrine System | No data available |
|
Pegvisomant 10mg inj vials
0605010Z0AAAAAA
|
Pegvisomant | Pegvisomant | Endocrine System | No data available |
|
Pegvisomant 15mg inj vials
0605010Z0AAABAB
|
Pegvisomant | Pegvisomant | Endocrine System | No data available |
|
Pegvisomant 20mg inj vials
0605010Z0AAACAC
|
Pegvisomant | Pegvisomant | Endocrine System | No data available |
|
Pegvisomant 25mg inj vials
0605010Z0AAADAD
|
Pegvisomant | Pegvisomant | Endocrine System | No data available |
|
Pegvisomant 30mg inj vials
0605010Z0AAAEAE
|
Pegvisomant | Pegvisomant | Endocrine System | No data available |
|
Pergoveris 150unit/75unit inj vials
0605010ABBBAAAA
|
Pergoveris | Follitropin alfa and lutropin alfa | Endocrine System | No data available |
|
Pergoveris 450units/225units/0.72ml inj pre-filled pens
0605010ABBBABAB
|
Pergoveris | Follitropin alfa and lutropin alfa | Endocrine System | No data available |
|
Pioglitazone 15mg/5ml oral suspension
0601023B0AAAEAE
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Pioglitazone 30mg/5ml oral suspension
0601023B0AAADAD
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Pioglitazone 45mg/5ml oral suspension
0601023B0AAAFAF
|
Pioglitazone hydrochloride | Pioglitazone hydrochloride | Endocrine System | No data available |
|
Pitressin 20units/1ml solution for injection ampoules
0605020W0BBAAAA
|
Pitressin | Argipressin | Endocrine System | No data available |
|
Plaobes 6mg/ml solution for injection 3ml pre-filled pens
0601023ABBHAAAA
|
Plaobes | Liraglutide | Endocrine System | No data available |
|
PocketScan testing strips
0601060D0BPAAA0
|
Pocket Scan (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Pork Actrapid 100units/ml solution for injection 10ml vials
0601011N0BFASAC
|
Insulin soluble (Novo-Nordisk) | Soluble insulin (Neutral insulin) | Endocrine System | No data available |
|
Pork Insulatard 100units/ml inj 10ml vials
0601012S0BDAAAB
|
Insulin isophane (Novo-Nordisk) | Isophane insulin | Endocrine System | No data available |
|
Pork Mixtard 30 100units/ml inj 10ml vials
0601012D0BCABAI
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.